Reshma Ramachandran

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Systemic Lupus Erythematosus

Clinical Practice

Affordable Care Act

Top Venues

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

The Journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Jennifer E Miller, William Pelletiers, Sakinah Suttiratana, Michael Ofosu Mensah, Jason Schwartz, Reshma Ramachandran, Cary Gross, Joseph R Ross
Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies. BMJ medicine 3 (1) (2024)
Reshma Ramachandran
If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Reshma Ramachandran
If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Reshma Ramachandran
If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Omar Qureshi, Reshma Ramachandran, Joseph R Ross
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data. Journal of pharmaceutical policy and practice 17 (1) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Angela Lu, Robin Z Ji, Marley P D Magee, Joseph R Ross, Reshma Ramachandran, Rita F Redberg, Sanket S Dhruva
Funding of evidence included within public comments submitted to inform Medicare national coverage determinations. Health affairs scholar 2 (6) (2024)
Angela Lu, Robin Z Ji, Marley P D Magee, Joseph R Ross, Reshma Ramachandran, Rita F Redberg, Sanket S Dhruva
Funding of evidence included within public comments submitted to inform Medicare national coverage determinations. Health affairs scholar 2 (6) (2024)
Reshma Ramachandran
If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Jennifer E Miller, William Pelletiers, Sakinah Suttiratana, Michael Ofosu Mensah, Jason Schwartz, Reshma Ramachandran, Cary Gross, Joseph R Ross
Harnessing policy to promote inclusive medical product evidence: development of a reference standard and structured audit of clinical trial diversity policies. BMJ medicine 3 (1) (2024)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology 51 (3) (2024)
Reshma Ramachandran
If Left Unchecked: Lessons Learned from Unfettered U.S. Government Support of the NIH-Moderna Vaccine. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 51 (S2) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Maryam Mooghali, Laura Glick, Reshma Ramachandran, Joseph S Ross
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ open 13 (1) (2023)
Maryam Mooghali, Laura Glick, Reshma Ramachandran, Joseph S Ross
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ open 13 (1) (2023)
Maryam Mooghali, Laura Glick, Reshma Ramachandran, Joseph S Ross
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ open 13 (1) (2023)
Maryam Mooghali, Laura Glick, Reshma Ramachandran, Joseph S Ross
Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study. BMJ open 13 (1) (2023)
Joshua J Skydel, Reshma Ramachandran, Sakinah C Suttiratana, Joseph R Ross, Christopher M Burns, Joshua D Wallach
Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies. The Journal of rheumatology (2023)
Reshma Ramachandran
Evidence and opportunity costs of lifestyle interventions in clinical medicine. BMJ medicine 1 (1) (2022)
Reshma Ramachandran
Evidence and opportunity costs of lifestyle interventions in clinical medicine. BMJ medicine 1 (1) (2022)